Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 3 × Pituitary Neoplasms × Cabergoline × Clear all

Phase

Phase 4 3 Phase 3 2 Phase NA 1 Phase 2 1

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 2 Prolactinoma 1 Pituitary ACTH Hypersecretion 1 Hyperprolactinemia 1 Adenoma 1 ACTH-Secreting Pituitary Adenoma 1

Interventions

pasireotide 2 Cabergoline 2 lanreotide 1 Solutions 1 Radiosurgery 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02288962 2025-06-08

Dopamine Agonist Treatment of Non-functioning Pituitary Adenomas

St. Olavs Hospital

Phase 3 Active not recruiting

Adenoma, Pituitary Neoplasms

NCT03271918 2017-09-07

Cabergoline in Nonfunctioning Pituitary Adenomas

University of Sao Paulo General Hospital

Phase 3 Completed

Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡